Time-Restricted Eating Plus Exercise May Cut Fat While Preserving Muscle
An 8-week trial tests whether a 16:8 fasting window combined with aerobic and resistance training outperforms normal eating for body composition.
Summary
This completed clinical trial investigated whether time-restricted feeding — eating within an 8-hour window and fasting for 16 hours — combined with both aerobic and resistance exercise is more effective than normal eating patterns for reducing fat mass while preserving muscle in overweight and obese adults. Over 8 weeks, 21 participants were assigned to either a time-restricted feeding group or a normal feeding group, both undergoing concurrent training. The study also tracked cardiovascular biomarkers, anabolic and catabolic hormones, and muscle strength and quality. The approach is appealing because, unlike traditional caloric restriction diets, time-restricted feeding does not necessarily require counting calories or eating less — just changing when you eat. Results were intended to clarify whether this dietary timing strategy is practical and effective for improving metabolic and muscular health simultaneously.
Detailed Summary
Obesity remains a major public health challenge in the United States, affecting both adolescents and adults at persistently high rates. While caloric restriction and exercise are proven tools for weight management, many traditional diets are nutritionally incomplete or difficult to maintain long-term. Time-restricted feeding (TRF) — limiting food intake to a set daily window, typically 8 hours — has emerged as a promising alternative that may sidestep some of these adherence problems.
This completed trial, sponsored by researcher Kyle Hackney, enrolled 21 overweight or obese adults and randomized them to either an 8-hour TRF protocol (16-hour daily fast) or a normal feeding (NF) control group. Both groups completed 8 weeks of concurrent aerobic and resistance training. The study aimed to determine whether TRF could reduce fat mass, preserve or increase fat-free mass, and improve cardiovascular and hormonal biomarkers compared to normal eating.
Results are not detailed in the available abstract, but the trial was designed to capture changes in body composition, cardiovascular risk markers, anabolic and catabolic hormones, muscle strength, and muscle quality. Prior research in resistance-trained men had shown TRF improved insulin sensitivity and reduced fat without losing muscle, lending biological plausibility to the approach.
For clinicians and health-conscious adults, this combination — structured meal timing with both aerobic and resistance exercise — represents a potentially sustainable strategy for improving metabolic health and body composition simultaneously. If TRF proves effective alongside exercise, it could offer a lower-burden alternative to calorie counting for patients struggling with obesity.
Key caveats include the small sample size of 21 participants, which limits statistical power and generalizability. The absence of published outcome data in the abstract means conclusions cannot yet be drawn. Additionally, this summary is based on the abstract and registration record only.
Key Findings
- Trial tested 8-hour eating window (16-hour fast) combined with aerobic and resistance training over 8 weeks.
- Primary goal was fat loss with preservation of muscle mass in overweight and obese adults.
- Cardiovascular biomarkers and anabolic-catabolic hormones were tracked as secondary outcomes.
- TRF does not require caloric restriction, potentially improving long-term adherence versus traditional diets.
- Earlier research in resistance-trained men showed TRF improved insulin sensitivity and maintained muscle.
Methodology
Randomized trial enrolling 21 overweight or obese adults assigned to either time-restricted feeding (8-hour window) or normal feeding, both combined with 8 weeks of concurrent aerobic and resistance training. Outcomes included body composition, cardiovascular markers, hormones, muscle strength, and quality. The trial was completed in March 2020.
Study Limitations
The sample size of 21 participants is small, limiting statistical power and generalizability to broader populations. Outcome data are not available in the abstract, so actual efficacy cannot be confirmed from this record alone. This summary is based on the abstract and trial registration only, and the full results may not yet be publicly published.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: